SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-026998
Filing Date
2023-05-03
Accepted
2023-05-03 16:45:44
Documents
1
Period of Report
2023-05-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4034
  Complete submission text file 0001209191-23-026998.txt   5328
Mailing Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421
Business Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421 617-314-6297
Keros Therapeutics, Inc. (Issuer) CIK: 0001664710 (see all company filings)

IRS No.: 811173868 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413
Business Address
Seth Alpna (Reporting) CIK: 0001721020 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39264 | Film No.: 23884902